The molecular mechanism of Trastuzumab resistance in Her2 overexpressing breast cancer cells

WAN Guang-wen,ZHANG Yan,LIU Bin

DOI: https://doi.org/10.3969/j.issn.1007-4287.2012.11.011

2012-01-01

Abstract:Objective It has been reported that resistance to the treatment with Trastuzumab in the in breast cancer cells,overexpressing Her2 gene,is associated with the overexpression of LC3.We explored the underlying Trastuzumab resistance mechanism of HER2 positive breast cancer cells through knocking down LC3 expression in SKBR3 Cells by using RNAi technology.Methods Wild type SKBR3 breast cancer cells and Trastuzumab resistant SKBR3 Cells were used as the research object.In both cell lines,LC3 protein level was examined.The expression of LC3 in Trastuzumab resistant SKBR3 Cells was suppressed by Lentiviral vectors.The mRNA and protein expression level of LC3 were examined by Real time PCR and western blotting respectively.The cell survival was examined by CCK-8 before and after LC3 knockdown.Results After Trastuzumab resistant SKBR3 Cells were transfected with the RNAi LC3 vector,The mRNA and protein expression level of LC3 were all downregulated significantly.Importantly,the survival fraction of LC3 knockdown group decreased significantly.Conclusion LC3 plays an important role in the resistance of HER2 positive breast cancer to Trastuzumab.Since LC3 is a well known marker of autophagy,therefore our findings indicate that autophagy plays pro-survival role and augments the resistance of HER2 positive breast cancer cells to Trastuzumab.